Table 5.
Risk Factors for Poor Tumor Differentiation in Patients With NSCLC Receiving Adjuvant Chemotherapy.
| Variables | Univariate Analysis | Multivariate Analysis | ||||||
|---|---|---|---|---|---|---|---|---|
| B | SE | 95% CI | P Value | B | SE | 95% CI | P Value | |
| MAC30 | 1.334 | 0.619 | 1.219-2.895 | .011 | 1.591 | 0.778 | 1.441-3.281 | .007 |
| Age | 1.108 | 0.411 | 0.802-1.885 | .482 | ||||
| Gender | 0.997 | 0.522 | 1.218-2.128 | .559 | ||||
| Smoking status | 1.291 | 0.642 | 1.003-2.318 | .429 | ||||
| Tumor classification | 1.331 | 0.717 | 1.109-2.835 | .297 | ||||
| Lymph node metastasis | 1.173 | 0.747 | 0.924-2.473 | .436 | ||||
Abbreviations: B, the parameter estimator of association coefficient; CI, confidence interval; NSCLC, non–small cell lung cancer; SE: standard error. Boldface values mean P < 0.05.